Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
42.2M
-
Shares change
-
+2.17M
-
Total reported value, excl. options
-
$1.12B
-
Value change
-
+$56.6M
-
Number of buys
-
50
-
Number of sells
-
-19
-
Price
-
$26.57
Significant Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q4 2020
87 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of Q4 2020.
Vaxcyte, Inc. - COMMON STOCK (PCVX) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.2M shares
of 130M outstanding shares and own 32.49% of the company stock.
Largest 10 shareholders include FMR LLC (7.64M shares), TPG Group Holdings (SBS) Advisors, Inc. (4.94M shares), JANUS HENDERSON GROUP PLC (4.2M shares), Abingworth LLP (4.17M shares), RA CAPITAL MANAGEMENT, L.P. (3.71M shares), FRAZIER MANAGEMENT LLC (2.31M shares), Pivotal bioVenture Partners Investment Advisor LLC (2.22M shares), Medicxi Ventures Management (Jersey) Ltd (1.89M shares), BlackRock Inc. (1.69M shares), and VANGUARD GROUP INC (1.45M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.